Showing 30,321 - 30,340 results of 226,405 for search '(( a ((linear decrease) OR (a decrease)) ) OR ( a ((largest decrease) OR (larger decrease)) ))', query time: 2.13s Refine Results
  1. 30321

    Supplementary Material for: A Scoping Review of Alternative Anticoagulation Strategies for Hemodialysis Patients with a Mechanical Heart Valve by Thomson B.K.A. (11712230)

    Published 2021
    “…We explored the evidence for alternative anticoagulation strategies in patients with ESRD with a contraindication for VKA therapy. <b><i>Methods:</i></b> A scoping review was completed, searching MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Web of Science, and Conference abstracts from inception to March 30, 2021. …”
  2. 30322

    Data Sheet 1_A rare PBX1 variant identified in adulthood: a case report.docx by Ah-Rim Han (2481865)

    Published 2025
    “…As part of the initial workup for decreased renal function and proteinuria, a kidney biopsy was performed, revealing focal segmental glomerulosclerosis (FSGS) and acute tubular necrosis without an identifiable cause. …”
  3. 30323

    Platelet-Activating Factor Receptor Plays a Role in Lung Injury and Death Caused by Influenza A in Mice by Cristiana C. Garcia (173379)

    Published 2010
    “…<div><p>Influenza A virus causes annual epidemics which affect millions of people worldwide. …”
  4. 30324

    CavA and Vfr are regulators of global intracellular c-di-GMP levels in <i>A. baumannii</i>. by Lyuboslava G. Harkova (19557062)

    Published 2024
    “…Deletion of <i>cavA</i> reduced c-di-GMP levels by 66% (<b>A</b>) while disruption of <i>vfr</i> decreased them by 49% (<b>B</b>). …”
  5. 30325

    A Sensory-Driven Trade-Off between Coordinated Motion in Social Prey and a Predator’s Visual Confusion by Bertrand H. Lemasson (636640)

    Published 2016
    “…Interestingly, while a complete loss of coordination in the prey (e.g., a flash expansion) caused the greatest delay in capture, such behavior had little effect on capture accuracy. …”
  6. 30326

    Beyond Estrogenicity: A Comparative Assessment of Bisphenol A and Its Alternatives in In Vitro Assays Questions Safety of Replacements by Vanessa Srebny (12565963)

    Published 2025
    “…Simulated phase I metabolism reduced the cytotoxicity of all alternatives except for methyl bis(4-hydroxyphenyl)acetate (Bz) and 4-[[4-(allyloxy)phenyl]sulfonyl]phenol (BPS-MAE), while estrogenic activity remained unchanged or decreased. This study demonstrates the utility of bioassays for rapid hazard assessment and comparative evaluation, suggesting that many BPA alternatives are regrettable substitutes, although 2,2,4,4-tetramethyl-1,3-cyclobutanediol (TMCD) is a potentially more benign alternative.…”
  7. 30327

    Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

    Published 2022
    “…Compound <b>4f</b> exhibited potent EGFR inhibitory activity with an IC<sub>50</sub> value of 61 nM compared to that of Tamoxifen (IC<sub>50</sub> value of 69 nM), with EGFR inhibition of 83 and 84%, respectively, at a concentration of 10 μM. Interestingly, <b>4f</b> showed remarkable PI3K/AKT/mTOR inhibitory activity with 0.18-, 0.27-, and 0.39-fold decrease in their concentration (reduction in controls from 6.64, 45.39, and 86.39 ng/mL to 1.24, 12.35, and 34.36 ng/mL, respectively). …”
  8. 30328

    Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

    Published 2022
    “…Compound <b>4f</b> exhibited potent EGFR inhibitory activity with an IC<sub>50</sub> value of 61 nM compared to that of Tamoxifen (IC<sub>50</sub> value of 69 nM), with EGFR inhibition of 83 and 84%, respectively, at a concentration of 10 μM. Interestingly, <b>4f</b> showed remarkable PI3K/AKT/mTOR inhibitory activity with 0.18-, 0.27-, and 0.39-fold decrease in their concentration (reduction in controls from 6.64, 45.39, and 86.39 ng/mL to 1.24, 12.35, and 34.36 ng/mL, respectively). …”
  9. 30329

    Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer by Daniel Pulido (61529)

    Published 2018
    “…In conclusion, by using a versatile multivalent chemical platform, we have developed a precise strategy to generate a true bivalent ligand that simultaneously targets both orthosteric sites of the D<sub>2</sub>R homodimer.…”
  10. 30330

    Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer by Daniel Pulido (61529)

    Published 2018
    “…In conclusion, by using a versatile multivalent chemical platform, we have developed a precise strategy to generate a true bivalent ligand that simultaneously targets both orthosteric sites of the D<sub>2</sub>R homodimer.…”
  11. 30331

    Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer by Daniel Pulido (61529)

    Published 2018
    “…In conclusion, by using a versatile multivalent chemical platform, we have developed a precise strategy to generate a true bivalent ligand that simultaneously targets both orthosteric sites of the D<sub>2</sub>R homodimer.…”
  12. 30332

    Substrate Access Mechanism in a Novel Membrane-Bound Phospholipase A of Pseudomonas aeruginosa Concordant with Specificity and Regioselectivity by Sabahuddin Ahmad (733766)

    Published 2021
    “…PlaF is a cytoplasmic membrane-bound phospholipase A<sub>1</sub> from Pseudomonas aeruginosa that alters the membrane glycerophospholipid (GPL) composition and fosters the virulence of this human pathogen. …”
  13. 30333

    Table1_A Comprehensive Analysis of HAVCR1 as a Prognostic and Diagnostic Marker for Pan-Cancer.DOCX by Sheng Liu (279488)

    Published 2024
    “…<p>Hepatitis A virus cellular receptor (HAVCR1) is a type-1 integral membrane glycoprotein that plays a key role in immunity and renal regeneration and is abnormally expressed in various tumor types. …”
  14. 30334

    Substrate Access Mechanism in a Novel Membrane-Bound Phospholipase A of Pseudomonas aeruginosa Concordant with Specificity and Regioselectivity by Sabahuddin Ahmad (733766)

    Published 2021
    “…PlaF is a cytoplasmic membrane-bound phospholipase A<sub>1</sub> from Pseudomonas aeruginosa that alters the membrane glycerophospholipid (GPL) composition and fosters the virulence of this human pathogen. …”
  15. 30335

    Maintenance of weight loss or stability in subjects with obesity: a retrospective longitudinal analysis of a real-world population by Maral DerSarkissian (504144)

    Published 2018
    “…</p> <p><b>Methods:</b> A retrospective observational longitudinal study of subjects with obesity was conducted using the General Electric Centricity electronic medical record database. …”
  16. 30336

    Substrate Access Mechanism in a Novel Membrane-Bound Phospholipase A of Pseudomonas aeruginosa Concordant with Specificity and Regioselectivity by Sabahuddin Ahmad (733766)

    Published 2021
    “…PlaF is a cytoplasmic membrane-bound phospholipase A<sub>1</sub> from Pseudomonas aeruginosa that alters the membrane glycerophospholipid (GPL) composition and fosters the virulence of this human pathogen. …”
  17. 30337

    ppGpp controls the expression of MglA/SspA-regulated genes in <i>F. tularensis</i>. by James C. Charity (257575)

    Published 2009
    “…(D) Venn diagram representation of the overlap between genes controlled by MglA and ppGpp. Each circle represents those genes whose expression was decreased by a factor of 2.5 or more (p<0.05) in the indicated mutant background compared to wild-type and whose expression altered by a factor of 2 or more in the other mutant background, as determined by DNA-microarray.…”
  18. 30338

    Supplementary Material for: Activin-A Is a Pro-Inflammatory Regulator in Type-2-Driven Upper Airway Disease by Chaker A.M. (5099003)

    Published 2018
    “…The correlated expression was found to be more pronounced in chronic disease with nasal polyps, showing substantially (48-fold) increased activin-A-producing cells in nasal polyps by ELISPOT, while submucosal downstream signalling as determined by confocal microscopy was decreased. …”
  19. 30339

    Substrate Access Mechanism in a Novel Membrane-Bound Phospholipase A of Pseudomonas aeruginosa Concordant with Specificity and Regioselectivity by Sabahuddin Ahmad (733766)

    Published 2021
    “…PlaF is a cytoplasmic membrane-bound phospholipase A<sub>1</sub> from Pseudomonas aeruginosa that alters the membrane glycerophospholipid (GPL) composition and fosters the virulence of this human pathogen. …”
  20. 30340

    Urinary Activin A is a novel biomarker reflecting renal inflammation and tubular damage in ANCA-associated vasculitis by Yoshinori Takei (302218)

    Published 2019
    “…Urinary activin A concentration decreased rapidly after immunosuppressive treatment. …”